Emmessar Biotech & Nutrition has informed that a meeting of the Board of Directors of the Company will be held on Tuesday the May 12, 2026, at Mumbai, To consider and approve Audited Financial Results of the Company for the year ended 31st March, 2026. Further, pursuant SEBI (Prohibition of Insider Trading), Regulations, 2015, as amended from time to time the Trading Window, as informed to the exchange vide letter dated 30.03.2026 in respect of trading in equity shares of the Company will remain closed up to May 14, 2026.
The above information is a part of company’s filings submitted to BSE.
